课题基金 / 基金详情

COVID-19 Variant Supplement - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.

COVID-19 Variant Supplement - Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
COVID-19 Variant Supplement - 通过基于机制的药物再利用和组合类器官筛选,计算机辅助发现与 Remdevisir 治疗 COVID-19 的协同药物组合。
批准号:
443137
负责人:
Cherkasov Artem
金额:
$3.64万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-02-01 至 2022-02-01

项目摘要

项目成果

Cherkasov Artem的其他基金

相关文献

中文摘要
翻译
随着全球超过400万例病例和超过30万例死亡,找到有效的COVID-19治疗方法并迅速找到它至关重要。结束大流行的希望在很大程度上依赖于新疫苗,但疫苗的开发通常
英文摘要
With more than 4 million cases and over 300,000 deaths worldwide, it is critical to find an effective treatment against COVID-19 and to find it fast. Hopes for ending the pandemic largely rely on new vaccines, however the development of vaccines typically
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Computer-aided discovery of synergistic drug combinations with Remdevisir for COVID-19 through mechanism-based drug repurposing and combinatorial organoid screening.
  • 批准号:
    429444
  • 项目类别:
    Operating Grants
  • 资助金额:
    $153.65万
  • 财政年份:
    2020
  • 负责人:
    Cherkasov Artem
  • 依托单位:
Sex as a Biological Variable Supplement - Augmented Discovery of Potential Inhibitors of SARS-CoV-2 3CL Protease
  • 批准号:
    424703
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2020
  • 负责人:
    Cherkasov Artem
  • 依托单位:
Canada Research Chair - Tier 1
  • 批准号:
    453866
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2020
  • 负责人:
    Cherkasov Artem
  • 依托单位: